Tirzepatide
Tirzepatide (LY3298176)
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied in glycemic and body-composition research.
Select size
Choose how to buy
Subscribe & save 5% on reshipsYour first order ships at the regular price. Every reship after that is 5% off. Pause, change the interval, or cancel anytime.
$135.00per vial · 20mg
Third-party tested · Purity 99% · For laboratory research use only.
- Purity
- 99%
- Form
- Powder (lyophilized)
- Available sizes
- 20mg, 40mg
Mechanism of Action
Research shows combined GIP/GLP-1 receptor agonism enhances insulin sensitivity, satiety signaling and lipid handling.
Research Areas
- ●Glycemic control research
- ●Appetite and satiety studies
- ●Metabolic syndrome models
Related Products
